Cash Flow

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Operating activities:    
Net loss $ (22,860) $ (20,144)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 1,174 1,314
Inventory allowance expense 161 0
Provision for doubtful accounts (119) 100
Loss on disposal of property and equipment 126 0
Loss (gain) on change in fair value of warrant liabilities 162 (4,851)
Stock-based compensation expense 2,232 1,755
Accretion of final payment fee of debt 64 72
Amortization of debt discounts 55 63
Gain on change in fair value of contingent liabilities (13) (72)
Common stock contribution to 401(k) plan 156 0
Loss on repurchase of warrants 0 1,067
Unrealized loss (gain) on foreign currency transactions 291 (425)
Changes in operating assets and liabilities:    
Accounts receivable (109) (488)
Inventories (1,254) (1,239)
Prepaid expense and other assets 831 (1,618)
Deferred costs of revenue 0 (86)
Accounts payable 1,058 (750)
Accrued liabilities 477 (577)
Deferred revenues 557 297
Net cash used in operating activities (17,011) (25,582)
Investing activities:    
Acquisition of property and equipment (51) (353)
Net cash used in investing activities (51) (353)
Financing activities:    
Proceeds from issuance of common stock and warrants, net 3,961 42,463
Principal payments on note payable (1,585) (46)
Proceeds from exercise of stock options 1 42
Net cash provided by financing activities 2,377 42,459
Effect of exchange rate changes on cash (133) 69
Net increase (decrease) in cash (14,818) 16,593
Cash at beginning of period 27,813 16,846
Cash at end of period 12,995 33,439
Supplemental disclosure of cash flow activities    
Cash paid for interest 350 309
Cash paid for income taxes 0 2
Supplemental disclosure of non-cash activities    
Transfer of inventory to equipment 757 417
Share issuance for common stock contribution to 401(k) plan 508 0
Share issuance for employee bonuses 230 0
Equipois sales earn-out 28 47
Equipois supply earn-out 0 189
Cumulative retrospective adjustment to retained earnings for ASU 2016-09 adoption 0 171
Repurchase of warrants and share issuance 0 2,245
April 2017 warrant issuance $ 0 $ 3,301

Source